Prudential Financial’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-400
| Closed | -$2.69K | – | 2780 |
|
|
2023
Q4 | $2.69K | Buy |
+400
| New | +$2.69K | ﹤0.01% | 2643 |
|
|
2023
Q1 | – | Sell |
-6,680
| Closed | -$236K | – | 2687 |
|
|
2022
Q4 | $236K | Buy |
6,680
+87
| +1% | +$3.08K | ﹤0.01% | 2349 |
|
|
2022
Q3 | $1.49M | Buy |
6,593
+4,548
| +222% | +$1.03M | ﹤0.01% | 1521 |
|
|
2022
Q2 | $387K | Buy |
+2,045
| New | +$387K | ﹤0.01% | 2231 |
|
|
2020
Q4 | – | Sell |
-534
| Closed | -$130K | – | 2514 |
|
|
2020
Q3 | $130K | Buy |
+534
| New | +$130K | ﹤0.01% | 2344 |
|
|
2020
Q2 | – | Sell |
-387
| Closed | -$79K | – | 2481 |
|
|
2020
Q1 | $79K | Buy |
+387
| New | +$79K | ﹤0.01% | 2283 |
|